These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8464197)

  • 1. [Atopic eczema with generalized lymph node swelling and deficient antibody formation despite repeat vaccination with live vaccines (measles, mumps)--atypical vaccination reaction, vaccination damage or vaccination failure?].
    Wiersbitzky S; Peters A; Bruns R; Pambor M
    Kinderarztl Prax; 1993 Feb; 61(1):34-6. PubMed ID: 8464197
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
    Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
    Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
    Halperin SA; McGrath P; Smith B; Houston T
    J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT; Frisch K; Kershaw DB; Sedman AB; Bunchman TE
    Adv Perit Dial; 1999; 15():269-72. PubMed ID: 10682116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical lymph-node hyperplasia after administration of attenuated, live measles vaccine.
    Allen MS; Talbot WH; McDonald RM
    N Engl J Med; 1966 Mar; 274(12):677-8. PubMed ID: 17926382
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of live mumps vaccine alone and in combination with measles vaccine in infants].
    Vesikari T; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
    Duodecim; 1982; 98(11):839-47. PubMed ID: 7106018
    [No Abstract]   [Full Text] [Related]  

  • 13. The Measles Control Campaign and immunisation adverse events.
    Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England.
    Miller E; Waight P
    BMJ; 1998 Jun; 316(7146):1745. PubMed ID: 9614036
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned?
    Watada B; Kennedy K; Chan D; Church B; Patriquin M; Shariff F; Evans MF
    Can Fam Physician; 1998 Jan; 44():53-5. PubMed ID: 9481462
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles vaccination in atopic dermatitis.
    Cherian T; John TJ
    Indian Pediatr; 1997 Jun; 34(6):555. PubMed ID: 9357215
    [No Abstract]   [Full Text] [Related]  

  • 17. Mumps vaccine virus strains and aseptic meningitis.
    Bonnet MC; Dutta A; Weinberger C; Plotkin SA
    Vaccine; 2006 Nov; 24(49-50):7037-45. PubMed ID: 16884835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection.
    Olesen AB; Juul S; Thestrup-Pedersen K
    Acta Derm Venereol; 2003; 83(6):445-50. PubMed ID: 14690341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
    Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
    Therapie; 1996; 51(6):677-80. PubMed ID: 9164004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coincidence of virus encephalitis and measles-mumps vaccination].
    Jorch G; Kleine M; Erwig H
    Monatsschr Kinderheilkd; 1984 May; 132(5):299-300. PubMed ID: 6146928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.